These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18499303)

  • 1. GABA(A) signalling is involved in N/OFQ anxiolytic-like effects but not in nocistatin anxiogenic-like action as evaluated in the mouse elevated plus maze.
    Gavioli EC; Duarte FS; Guerrini R; Calo G; Rae GA; M De Lima TC
    Peptides; 2008 Aug; 29(8):1404-12. PubMed ID: 18499303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.
    Vitale G; Arletti R; Ruggieri V; Cifani C; Massi M
    Peptides; 2006 Sep; 27(9):2193-200. PubMed ID: 16730097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the GABA/benzodiazepine receptor in the axiolytic-like effect of nociceptin/orphanin FQ.
    Uchiyama H; Yamaguchi T; Toda A; Hiranita T; Watanabe S; Eyanagi R
    Eur J Pharmacol; 2008 Aug; 590(1-3):185-9. PubMed ID: 18586237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor.
    Okuda-Ashitaka E; Ito S
    Peptides; 2000 Jul; 21(7):1101-9. PubMed ID: 10998544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
    Fernandez F; Misilmeri MA; Felger JC; Devine DP
    Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.
    Gavioli EC; Rae GA; Calo' G; Guerrini R; De Lima TC
    Br J Pharmacol; 2002 Jul; 136(5):764-72. PubMed ID: 12086986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of amygdaloid nuclei in the anxiolytic-like effect of nociceptin/orphanin FQ in rats.
    Uchiyama H; Toda A; Hiranita T; Watanabe S; Eyanagi R
    Neurosci Lett; 2008 Jan; 431(1):66-70. PubMed ID: 18166271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.
    Aujla H; Cannarsa R; Romualdi P; Ciccocioppo R; Martin-Fardon R; Weiss F
    Addict Biol; 2013 May; 18(3):467-79. PubMed ID: 22804785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intrathecal nocistatin on nociceptin/orphanin FQ analgesia in chronic constriction injury rat.
    Ma F; Xie H; Dong ZQ; Wang YQ; Wu GC
    Brain Res; 2003 Oct; 988(1-2):189-92. PubMed ID: 14519541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively.
    Inoue M; Kawashima T; Allen RG; Ueda H
    J Pharmacol Exp Ther; 2003 Jul; 306(1):141-6. PubMed ID: 12665541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
    Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
    Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
    Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
    Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor.
    Ahmadi S; Kotalla C; Gühring H; Takeshima H; Pahl A; Zeilhofer HU
    Mol Pharmacol; 2001 Mar; 59(3):612-8. PubMed ID: 11179457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
    Hiramatsu M; Inoue K
    Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
    Fantin M; Fischetti C; Trapella C; Morari M
    Br J Pharmacol; 2007 Oct; 152(4):549-55. PubMed ID: 17618307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain regulation by nocistatin-targeting molecules: G protein-coupled-receptor and nocistatin-interacting protein.
    Okuda-Ashitaka E; Ito S
    Vitam Horm; 2015; 97():147-65. PubMed ID: 25677771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.
    Nakano H; Minami T; Abe K; Arai T; Tokumura M; Ibii N; Okuda-Ashitaka E; Mori H; Ito S
    J Pharmacol Exp Ther; 2000 Jan; 292(1):331-6. PubMed ID: 10604967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocistatin attenuated the nociceptin induced c-Fos expression in the mouse hippocampus.
    Kazi JA; Liu EH; Lee TL; Tachibana S
    Neuropeptides; 2007 Aug; 41(4):227-31. PubMed ID: 17586043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose Nociceptin/Orphanin FQ reduces anxiety-like performance in alcohol-withdrawn, but not alcohol-naïve, Male Wistar rats.
    Aujla H; Nedjadrasul D
    Neuropharmacology; 2015 Jun; 93():1-6. PubMed ID: 25617519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.